CONA
ABBV icon

Capital One National Association’s AbbVie ABBV Stock Holding History

Capital One National Association’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.01M Buy
+11,461
New +$951K 0.13% 141
2018
Q2 		$13.4M Sell
144,484
-5,545
-4% -$542K 0.97% 18
2018
Q1 		$14.2M Sell
150,029
-2,981
-2% -$327K 0.99% 19
2017
Q4 		$14.8M Buy
153,010
+4,671
+3% +$440K 1% 21
2017
Q3 		$13.2M Buy
148,339
+5,869
+4% +$447K 0.92% 20
2017
Q2 		$10.3M Buy
142,470
+4,685
+3% +$315K 0.75% 27
2017
Q1 		$8.98M Sell
137,785
-3,555
-3% -$224K 0.67% 30
2016
Q4 		$8.85M Buy
141,340
+52,780
+60% +$3.22M 0.66% 31
2016
Q3 		$5.58M Buy
88,560
+41,411
+88% +$2.68M 0.45% 62
2016
Q2 		$2.92M Buy
47,149
+8,913
+23% +$543K 0.24% 87
2016
Q1 		$2.18M Sell
38,236
-1,377
-3% -$76.7K 0.2% 106
2015
Q4 		$2.35M Sell
39,613
-1,551
-4% -$89.3K 0.2% 107
2015
Q3 		$2.24M Sell
41,164
-1,123
-3% -$73.1K 0.22% 108
2015
Q2 		$2.84M Sell
42,287
-9,206
-18% -$601K 0.25% 95
2015
Q1 		$3.01M Sell
51,493
-6,905
-12% -$417K 0.27% 88
2014
Q4 		$3.82M Sell
58,398
-3,299
-5% -$208K 0.37% 73
2014
Q3 		$3.56M Sell
61,697
-8,481
-12% -$471K 0.35% 89
2014
Q2 		$3.96M Buy
70,178
+4,357
+7% +$229K 0.37% 79
2014
Q1 		$3.38M Sell
65,821
-2,703
-4% -$137K 0.33% 89
2013
Q4 		$3.62M Sell
68,524
-3,467
-5% -$170K 0.35% 82
2013
Q3 		$3.22M Sell
71,991
-28,920
-29% -$1.28M 0.33% 85
2013
Q2 		$4.17M Buy
+100,911
New +$4.41M 0.45% 58

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital One National Association's ABBV Position: Q4 2019 in Review

Capital One National Association opened a new position in AbbVie (ABBV) in Q4 2019: 11,461 shares worth $1.01M. The stake represents 0.13% of the portfolio and ranks #141 among its holdings. This is a return to the name: Capital One National Association previously reported a position in ABBV as recently as Q2 2018.

Capital One National Association first reported a position in ABBV in Q2 2013 and has held it in 22 quarters since. The position peaked at $14.8M in Q4 2017. 2,244 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Capital One National Association held 11,461 shares of AbbVie worth $1.01M as of Q4 2019.
  • AbbVie was a new Capital One National Association position in Q4 2019.
  • AbbVie made up 0.13% of Capital One National Association's portfolio in Q4 2019, its #141 holding.
  • Capital One National Association first reported a position in AbbVie in Q2 2013 and has held it in 22 quarters since.
  • Capital One National Association's AbbVie position peaked at $14.8M in Q4 2017.
  • 2,244 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Capital One National Association's 13F filing for Q4 2019, filed 11 Feb 2020.